This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

George R. Gay, MD
California Medical Facility-Main Vacaville

JAMA. 1991;265(15):1951.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Dr Graham objects to my suggestion of "careful and serial" monitoring of liver functions, suggesting that this wording places an unnecessary burden on the prescribing physician and indeed may make him or her more liable to litigation.

As part of my conclusion, I stated, "We would be well advised, then, to monitor liver functions (especially the transaminases) carefully and serially in any patient undergoing long-term NSAID therapy." I further recommended baseline liver profile studies in any individual suspected to be at risk for hepatic injury (as briefly outlined, alcohol or other drug abusers, those debilitated or immunocompromised, those testing positive for the human immunodeficiency virus or at risk for the acquired immunodeficiency virus, those with a history of foreign travel, those exposed to toxic industrial products or hepatitis, those receiving blood transfusions, or those with a "chronic pain" problem with attendant "overmedication," either "self" or iatrogenic.

Dr Graham . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?